• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Low Breast Density Could Indicate Poor Prognosis, Study Suggests

Article

The findings of this study, conducted in Finland, may prove significant for the assessment of breast cancer prognosis and treatment planning.

Very low mammographic breast density worsens the prognosis of breast cancer, according to a recent study from the University of Eastern Finland. Disease free survivals as well as overall life expectancies were significantly shorter in women with very low-density breasts in comparison to women with high density breast tissue. The lower the breast tissue density, the less fibroglandular tissue there is compared to fat tissue.

In the future, these findings may prove significant for the assessment of breast cancer prognosis and treatment planning.

The study involved 270 breast cancer patients at Kuopio University Hospital, aged between 32 and 86 years. Breast tissue density was analysed on the basis of mammographic images obtained at the time of diagnosis. The researchers determined the proportion of dense glandular tissue of the overall breast area. Breast tissue density was categorised as low when the proportion of glandular tissue was below 25%, and as very low when the proportion of glandular tissue was below 10%. The study was a 6-year follow up focusing on the effects of breast tissue density and other mammographic features on breast cancer prognosis.

Complete article in Financial Express:

http://bit.ly/1EbfLoO

Related Videos
Will Shapiro, vice president of data science, Flatiron Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Will Shapiro, vice president of data science, Flatiron Health
Jonathan E. Levitt, Esq, Frier Levitt, LLC
Judy Alberto, MHA, RPh, BCOP, Community Oncology Alliance
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Emily Touloukian, DO, Coastal Cancer Center
Will Shapiro
Mila Felder, MD, FACEP
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.